Analysts Set Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) PT at $34.57
Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) have earned a consensus recommendation of “Buy” from the eight analysts that are currently covering the firm, Marketbeat.com reports. Seven investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year […]
Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) have earned a consensus recommendation of “Buy” from the eight analysts that are currently covering the firm, Marketbeat.com reports. Seven investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year […]
